(-0.69%) 4 976.50 points
(0.33%) 37 901 points
(-1.64%) 15 346 points
(0.33%) $83.00
(-0.68%) $1.745
(0.49%) $2 409.70
(1.06%) $28.68
(-1.48%) $940.40
(-0.02%) $0.939
(-0.10%) $11.03
(0.44%) $0.808
(-0.97%) $92.99
Live Chart Being Loaded With Signals
Anhui Anke Biotechnology (Group) Co., Ltd. develops, produces, and markets pharmaceutical products in China and internationally. The company offers recombinant human growth hormone for injection under the Ansomone name; and recombinant human interferon alpha 2b lyophilized powder, liquid, and prefilled syringe for injection, as well as recombinant human interferon alpha 2b cream, eye drop, and suppository under the Anterferon name...
Stats | |
---|---|
Today's Volume | 13.29M |
Average Volume | 14.60M |
Market Cap | 15.97B |
EPS | CNY0.149 ( 2023-10-24 ) |
Last Dividend | CNY0 ( N/A ) |
Next Dividend | CNY0 ( N/A ) |
P/E | 19.16 |
ATR14 | CNY0.0150 (0.15%) |
Volume Correlation
Anhui Anke Biotechnology Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Anhui Anke Biotechnology Correlation - Currency/Commodity
Anhui Anke Biotechnology Financials
Annual | 2023 |
Revenue: | CNY2.84B |
Gross Profit: | CNY2.18B (76.61 %) |
EPS: | CNY0.520 |
Q4 | 2023 |
Revenue: | CNY836.86M |
Gross Profit: | CNY644.84M (77.05 %) |
EPS: | CNY0.120 |
Q3 | 2023 |
Revenue: | CNY734.10M |
Gross Profit: | CNY580.77M (79.11 %) |
EPS: | CNY0.160 |
Q2 | 2023 |
Revenue: | CNY693.11M |
Gross Profit: | CNY553.35M (79.84 %) |
EPS: | CNY0.130 |
Financial Reports:
No articles found.
Anhui Anke Biotechnology
Anhui Anke Biotechnology (Group) Co., Ltd. develops, produces, and markets pharmaceutical products in China and internationally. The company offers recombinant human growth hormone for injection under the Ansomone name; and recombinant human interferon alpha 2b lyophilized powder, liquid, and prefilled syringe for injection, as well as recombinant human interferon alpha 2b cream, eye drop, and suppository under the Anterferon name. It also provides anti-sperm antibody, semen leukocyte peroxidase staining, one-time semen processing, sperm hypo-osmotic staining, sperm life detection, sperm staining detection, sperm acrosin detection, sperm DNA fragmentation staining, and leptin and immunohistochemical diagnostic kits. In addition, the company offers adhesive plasters, oral solutions, topical preparations, and ointments; peptide APIs; beauty care and anti-aging products; and synthetic drugs in the form of oral powders, dripping pills, and tablets and capsules. Further, it provides autosomal, sex chromosome, autosomal and sex chromosome combination, and other kits, as well as paternity testing set packages; tumor biological immunotherapy products; and DNA testing professional services. The company was founded in 2000 and is based in Hefei, China.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators